Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
United Therapeutics Corporation (UTHR)
USD535.57
-11.49 (-2.10%)
US NASDAQ Healthcare Biotechnology
Address
1040 Spring Street 20910
Silver Spring, MD, US
Silver Spring, MD, US
CEO
Martine A. Rothblatt
Website
unither.com
IPO
1999-06-17
CIK 1082554 ISIN US91307C1027
Description
United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.
News Sentiment (7d)
Based on only 1 article — low confidence
- United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD535.57
-11.49 (-2.10%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
507.2K
Beta
0.57
Float Shares
42.28M
Free Float %
96.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.87% | -4.86% | -0.32% | +19.69% | +23.47% | +16.96% | +83.36% | +166.27% | +191.51% | +421.72% | +9,251.88% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (30 ratings, all time)
Buy
Price Targets & DCF
Current price
535.57
Low
516.00
-3.7%
Consensus
628.00
+17.3%
Median
625.00
+16.7%
High
735.00
+37.2%
DCF (Unlevered)
812.21
+51.7%
DCF (Levered)
958.72
+79.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
73% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 9 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
609.50
+13.8%
|
| Last Quarter | 4 |
611.00
+14.1%
|
| Last Year | 16 |
549.75
+2.6%
|
| All Time | 35 |
424.86
-20.7%
|
Quality scores
Altman Z-Score
21.22
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
8 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
★ Strong MOAT
-
Revenue growth Biotechnology: +1.6%+10.6% ★ Q1'26: -1.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+13.1% Q1'26: -12.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+38.6% Q1'26: +46.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+54.5% ★ Q1'26: +41.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+24.4% ★ Q1'26: +30.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-1.2% ★ Q1'26: -2.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× ★ Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 11 EPS Ana. |
Dec 2027 11 Rev. Ana. 11 EPS Ana. |
Dec 2028 10 Rev. Ana. 10 EPS Ana. |
Dec 2029 5 Rev. Ana. 4 EPS Ana. |
Dec 2030 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
743.18M
est: 918.64M (-19.1%)
|
916.08M
est: 820.04M (+11.7%)
|
1.12B
est: 1.71B (-34.8%)
|
1.29B
est: 2.02B (-36.1%)
|
1.47B
est: 1.45B (+1.3%)
|
1.60B
est: 1.61B (-0.5%)
|
1.73B
est: 1.68B (+2.8%)
|
1.63B
est: 1.61B (+1.4%)
|
1.45B
est: 1.50B (-3.1%)
|
1.48B
est: 1.46B (+1.6%)
|
1.69B
est: 1.70B (-0.7%)
|
1.94B
est: 1.96B (-1.4%)
|
2.33B
est: 2.62B (-11.1%)
|
2.88B
est: 2.87B (+0.1%)
|
3.18B
est: 3.20B (-0.6%)
|
3.26B
3.17B – 3.36B
+1.9% YoY
|
3.70B
3.25B – 4.30B
+13.6% YoY
|
4.27B
4.27B – 4.27B
+15.4% YoY
|
5.13B
4.65B – 5.67B
+20.1% YoY
|
6.19B
5.60B – 6.83B
+20.5% YoY
|
| EBITDA |
341.02M
est: 296.72M (+14.9%)
|
484.46M
est: 400.49M (+21.0%)
|
323.76M
est: 351.07M (-7.8%)
|
575.02M
est: 406.37M (+41.5%)
|
1.08B
est: 746.99M (+44.9%)
|
1.09B
est: 862.56M (+26.5%)
|
1.05B
est: 734.55M (+43.4%)
|
838.40M
est: 646.33M (+29.7%)
|
-74.90M
est: -3.00B (+97.5%)
|
646.30M
est: 341.35M (+89.3%)
|
736.80M
est: 683.12M (+7.9%)
|
1.04B
est: 751.43M (+38.4%)
|
1.39B
est: 1.80B (-22.9%)
|
1.65B
est: 1.98B (-16.2%)
|
1.82B
est: 2.20B (-17.3%)
|
2.24B
2.18B – 2.31B
+1.9% YoY
|
2.55B
2.23B – 2.96B
+13.6% YoY
|
2.94B
2.94B – 2.94B
+15.4% YoY
|
3.53B
3.20B – 3.90B
+20.1% YoY
|
4.25B
3.85B – 4.70B
+20.5% YoY
|
| EBIT |
320.48M
est: 294.96M (+8.7%)
|
457.31M
est: 337.67M (+35.4%)
|
292.50M
est: 300.91M (-2.8%)
|
542.77M
est: 366.85M (+48.0%)
|
1.05B
est: 925.49M (+13.4%)
|
1.06B
est: 833.91M (+27.0%)
|
1.02B
est: 775.95M (+31.8%)
|
802.50M
est: 658.65M (+21.8%)
|
-120.80M
est: -3.22B (+96.3%)
|
596.40M
est: 534.54M (+11.6%)
|
686.90M
est: 513.92M (+33.7%)
|
989.00M
est: 565.32M (+74.9%)
|
1.33B
est: 1.74B (-23.3%)
|
1.58B
est: 1.91B (-17.1%)
|
1.73B
est: 2.13B (-18.5%)
|
2.17B
2.11B – 2.23B
+1.9% YoY
|
2.46B
2.16B – 2.86B
+13.6% YoY
|
2.84B
2.84B – 2.84B
+15.4% YoY
|
3.41B
3.09B – 3.77B
+20.1% YoY
|
4.11B
3.72B – 4.54B
+20.5% YoY
|
| Net Income |
217.87M
est: 181.80M (+19.8%)
|
304.44M
est: 253.17M (+20.3%)
|
174.56M
est: 165.18M (+5.7%)
|
340.07M
est: 225.65M (+50.7%)
|
651.64M
est: 891.60M (-26.9%)
|
713.70M
est: 557.29M (+28.1%)
|
417.90M
est: 176.81M (+136.4%)
|
589.20M
est: 458.17M (+28.6%)
|
-104.50M
est: -2.40B (+95.7%)
|
514.80M
est: 481.19M (+7.0%)
|
475.80M
est: 484.39M (-1.8%)
|
727.30M
est: 532.82M (+36.5%)
|
984.80M
est: 1.07B (-7.9%)
|
1.20B
est: 1.24B (-3.8%)
|
1.33B
est: 1.29B (+3.7%)
|
1.28B
1.27B – 1.50B
-0.6% YoY
|
1.51B
1.19B – 1.92B
+17.9% YoY
|
1.75B
1.30B – 2.27B
+15.8% YoY
|
2.27B
1.99B – 2.57B
+29.7% YoY
|
2.72B
2.39B – 3.09B
+20.2% YoY
|
| SGA |
156.48M
est: 161.41M (-3.1%)
|
201.75M
est: 176.64M (+14.2%)
|
394.01M
est: 611.99M (-35.6%)
|
381.29M
est: 560.48M (-32.0%)
|
452.61M
est: 690.75M (-34.5%)
|
316.80M
est: 326.76M (-3.0%)
|
330.10M
est: 479.11M (-31.1%)
|
265.80M
est: 298.24M (-10.9%)
|
336.20M
est: 749.77M (-55.2%)
|
423.90M
est: 381.20M (+11.2%)
|
467.00M
est: 553.20M (-15.6%)
|
487.00M
est: 608.52M (-20.0%)
|
477.10M
est: 620.27M (-23.1%)
|
638.60M
est: 681.14M (-6.2%)
|
731.10M
est: 758.64M (-3.6%)
|
772.68M
751.41M – 796.31M
+1.9% YoY
|
878.08M
769.20M – 1.02B
+13.6% YoY
|
1.01B
1.01B – 1.01B
+15.4% YoY
|
1.22B
1.10B – 1.34B
+20.1% YoY
|
1.47B
1.33B – 1.62B
+20.5% YoY
|
| EPS |
3.81
est: 2.75 (+38.5%)
|
5.84
est: 3.85 (+51.7%)
|
3.49
est: 8.44 (-58.6%)
|
7.06
est: 8.28 (-14.7%)
|
14.17
est: 13.16 (+7.7%)
|
16.29
est: 16.38 (-0.5%)
|
9.50
est: 12.74 (-25.4%)
|
13.54
est: 13.98 (-3.2%)
|
-2.39
est: -0.82 (-191.5%)
|
11.65
est: 12.77 (-8.8%)
|
10.60
est: 11.38 (-6.9%)
|
15.98
est: 17.52 (-8.8%)
|
21.04
est: 23.07 (-8.8%)
|
26.44
est: 24.41 (+8.3%)
|
30.13
est: 27.48 (+9.6%)
|
28.63
26.46 – 31.36
+4.2% YoY
|
33.67
24.78 – 40.08
+17.6% YoY
|
39.16
27.13 – 47.46
+16.3% YoY
|
47.30
41.52 – 53.75
+20.8% YoY
|
56.84
49.90 – 64.59
+20.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.10B
OE per share TTM
23.16
Owner's Yield
4.24%
Maintenance CapEx ratio
38.90%
Maint CapEx / Avg PPE
47.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
309
Total invested
2.39B
Insider transactions (90d)
0
Beneficial owners (>5%)
28
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2. | 7.97M | 6.51% | — | — | — | 7.97M | CO | — | 2023-02-03 | ↗ |
| 2 | (1) BlackRock, Inc. | 4.24M | 9.40% | 4.05M | — | 4.24M | — | HC | Delaware | 2022-02-03 | ↗ |
| 3 | The Vanguard Group - 23-1945930 | 4.16M | 9.24% | — | 24.0K | 4.10M | 61.8K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 4 | Martine A. Rothblatt | 4.12M | 8.50% | 4.12M | — | 4.12M | — | IN | United States of America | 2022-02-04 | ↗ |
| 5 | United Therapeutics Corporation | 3.66M | 5.88% | 3.66M | — | 3.66M | — | CO | Delaware | 2022-01-14 | ↗ |
| 6 | Avoro Capital Advisors LLC | 3.04M | 6.70% | 3.04M | — | 3.04M | — | IA, OO | Delaware | 2022-02-11 | ↗ |
| 7 | Behzad Aghazadeh | 3.04M | 6.70% | 3.04M | — | 3.04M | — | IN | United States | 2022-02-11 | ↗ |
| 8 | 13-3127734 | 2.92M | 6.48% | 2.91M | — | 2.92M | — | HC | Delaware | 2022-02-11 | ↗ |
| 9 | 26-0385758 | 2.92M | 6.48% | 2.91M | — | 2.92M | — | IA | Delaware | 2022-02-11 | ↗ |
| 10 | Wellington Group Holdings LLP | 2.57M | 5.64% | — | 2.15M | — | — | HC | Delaware | 2023-02-06 | ↗ |
| 11 | Wellington Investment Advisors Holdings LLP | 2.57M | 5.64% | — | 2.15M | — | — | HC | Delaware | 2023-02-06 | ↗ |
| 12 | Wellington Management Group LLP | 2.57M | 5.64% | — | 2.15M | — | — | HC | Delaware | 2023-02-06 | ↗ |
| 13 | Abigail P. Johnson | 2.38M | 5.43% | — | — | 2.38M | — | IN | Delaware | 2020-02-07 | ↗ |
| 14 | FMR LLC | 2.32M | 5.23% | — | — | 2.32M | — | HC | United States of America | 2021-02-08 | ↗ |
| 15 | STATE STREET CORPORATION | 2.24M | 5.00% | — | 2.02M | — | — | HC | MA | 2024-10-16 | ↗ |
| 16 | Lung Biotechnology PBC | 1.46M | 6.89% | — | 1.46M | — | — | CO | Delaware | 2020-02-07 | ↗ |
| 17 | Israel A. Englander | 1.21M | 2.80% | — | 1.21M | — | 1.21M | IN | — | 2020-02-13 | ↗ |
| 18 | Millennium Group Management LLC | 1.21M | 2.80% | — | 1.21M | — | 1.21M | OO | — | 2020-02-13 | ↗ |
| 19 | Millennium Management LLC | 1.21M | 2.80% | — | 1.21M | — | 1.21M | OO | — | 2020-02-13 | ↗ |
| 20 | Integrated Core Strategies (US) LLC | 1.14M | 2.60% | — | 1.14M | — | 1.14M | OO | — | 2020-02-13 | ↗ |
| 21 | AQR Capital Management Holdings, LLC | 671.1K | 1.53% | — | 671.1K | — | — | HC | Delaware, USA | 2020-02-14 | ↗ |
| 22 | AQR Capital Management, LLC | 671.1K | 1.53% | — | 671.1K | — | — | IA | Delaware, USA | 2020-02-14 | ↗ |
| 23 | Millennium International Management LP | 77.6K | 0.20% | — | 77.6K | — | 77.6K | PN | — | 2020-02-13 | ↗ |
| 24 | Integrated Assets II LLC | 62.5K | 0.10% | — | 62.5K | — | 62.5K | OO | — | 2020-02-13 | ↗ |
| 25 | ICS Opportunities, Ltd. | 7.9K | 0.00% | — | 7.9K | — | 7.9K | CO | — | 2020-02-13 | ↗ |
| 26 | Integrated Assets, Ltd. | 6.4K | 0.00% | — | 6.4K | — | 6.4K | CO | — | 2020-02-13 | ↗ |
| 27 | ICS Opportunities II LLC | 900.00 | 0.00% | — | 900.00 | — | 900.00 | OO | — | 2020-02-13 | ↗ |
| 28 | s | — | 0.00% | — | — | — | — | CO | Delaware | 2021-02-05 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
309
-541 vs prev Q
New positions
38
Closed positions
559
Increased
138
Reduced
112
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 5.17M -182.2K (-3.4%) | 2.52B +275.4M (+12.3%) | 11.81% -0.064 pp | 0.04% +0.003 pp | USD357.72 +36.2% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 4.18M -242.6K (-5.5%) | 2.03B +182.4M (+9.8%) | 9.53% -0.263 pp | 0.03% +0.002 pp | USD107.20 +354.5% | 84 qtrs — |
| 3 | AVORO CAPITAL ADVISORS LLC | 2.61M +583.8K (+28.9%) | 1.27B +422.1M (+49.8%) | 5.95% +1.466 pp | 12.21% +1.250 pp | USD229.04 +112.7% | 21 qtrs — |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 2.44M +1.0M (+74.5%) | 1.19B +603.2M (+102.9%) | 5.57% +2.473 pp | 0.21% +0.106 pp | USD340.18 +43.2% | 21 qtrs — |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 1.91M -264.1K (-12.2%) | 930.29M +19.2M (+2.1%) | 4.36% -0.460 pp | 1.44% +0.240 pp | USD129.79 +275.4% | 79 qtrs — |
| 6 | STATE STREET CORP | 1.84M -80.2K (-4.2%) | 897.71M +91.7M (+11.4%) | 4.21% -0.057 pp | 0.03% +0.002 pp | USD167.94 +190.1% | 51 qtrs — |
| 7 | AQR CAPITAL MANAGEMENT LLC | 1.28M +295.2K (+29.9%) | 624.51M +211.0M (+51.0%) | 2.93% +0.739 pp | 0.33% +0.063 pp | USD305.22 +59.6% | 66 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.19M -56.6K (-4.5%) | 580.24M +57.3M (+11.0%) | 2.72% -0.047 pp | 0.04% +0.002 pp | USD215.49 +126.1% | 78 qtrs — |
| 9 | JANUS HENDERSON GROUP PLC | 796.1K +341.4K (+75.1%) | 387.80M +197.2M (+103.5%) | 1.82% +0.809 pp | 0.17% +0.087 pp | USD385.42 +26.4% | 43 qtrs — |
| 10 | ASSETMARK, INC | 635.0K -11.0K (-1.7%) | 309.38M +38.6M (+14.3%) | 1.45% +0.018 pp | 0.63% +0.051 pp | USD258.62 +88.4% | 41 qtrs — |
| 11 | INVESCO LTD. | 608.8K -28.5K (-4.5%) | 296.62M +29.5M (+11.0%) | 1.39% -0.023 pp | 0.05% +0.003 pp | USD262.88 +85.4% | 57 qtrs — |
| 12 | NORGES BANK | 602.2K +602.2K (+100.0%) | 293.42M +293.4M (+100.0%) | 1.37% +1.375 pp | 0.03% +0.031 pp | USD487.25 +0.0% | 1 qtrs NEW |
| 13 | DIMENSIONAL FUND ADVISORS LP | 528.2K +15.4K (+3.0%) | 257.41M +42.4M (+19.7%) | 1.21% +0.069 pp | 0.05% +0.008 pp | USD162.54 +199.8% | 51 qtrs — |
| 14 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 426.0K +— (+0.0%) | 207.57M +29.0M (+16.2%) | 0.97% +0.028 pp | 2.65% -0.075 pp | USD298.00 +63.5% | 4 qtrs — |
| 15 | NORTHERN TRUST CORP | 418.4K -28.6K (-6.4%) | 203.88M +16.5M (+8.8%) | 0.96% -0.036 pp | 0.03% +0.002 pp | USD200.02 +143.6% | 51 qtrs — |
| 16 | LSV ASSET MANAGEMENT | 408.1K -278.6K (-40.6%) | 198.83M -89.0M (-30.9%) | 0.93% -0.591 pp | 0.43% -0.202 pp | USD228.15 +113.6% | 56 qtrs — |
| 17 | FMR LLC | 403.8K +153.5K (+61.3%) | 196.77M +91.8M (+87.5%) | 0.92% +0.367 pp | 0.01% +0.005 pp | USD330.61 +47.4% | 70 qtrs — |
| 18 | MORGAN STANLEY | 389.3K -49.5K (-11.3%) | 189.68M +5.7M (+3.1%) | 0.89% -0.084 pp | 0.01% +0.000 pp | USD270.65 +80.0% | 51 qtrs — |
| 19 | PRICE T ROWE ASSOCIATES INC /MD/ | 352.1K +51.2K (+17.0%) | 171.56M +45.4M (+36.0%) | 0.80% +0.137 pp | 0.02% +0.005 pp | USD399.02 +22.1% | 75 qtrs — |
| 20 | BANK OF NEW YORK MELLON CORP | 333.6K -17.8K (-5.1%) | 162.56M +15.2M (+10.3%) | 0.76% -0.018 pp | 0.03% +0.000 pp | USD147.24 +230.9% | 66 qtrs — |
| 21 | SWEDBANK AB | 324.8K -4.3K (-1.3%) | 158.25M +20.3M (+14.7%) | 0.74% +0.012 pp | 0.15% +0.013 pp | USD170.71 +185.4% | 20 qtrs — |
| 22 | BAILLIE GIFFORD & CO | 323.0K +323.0K (+100.0%) | 157.39M +157.4M (+100.0%) | 0.74% +0.738 pp | 0.13% +0.131 pp | USD487.25 +0.0% | 1 qtrs NEW |
| 23 | PICTET ASSET MANAGEMENT HOLDING SA | 306.8K -14.7K (-4.6%) | 149.67M +14.8M (+11.0%) | 0.70% -0.012 pp | 0.15% +0.015 pp | USD342.70 +42.2% | 10 qtrs — |
| 24 | D. E. SHAW & CO., INC. | 307.0K +242.3K (+374.4%) | 149.57M +122.4M (+451.4%) | 0.70% +0.557 pp | 0.08% +0.067 pp | USD461.65 +5.5% | 45 qtrs — |
| 25 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 296.3K +198.2K (+201.9%) | 144.38M +103.2M (+251.0%) | 0.68% +0.459 pp | 0.24% +0.171 pp | USD417.44 +16.7% | 12 qtrs — |
| 26 | FULLER & THALER ASSET MANAGEMENT, INC. | 290.6K -24.7K (-7.8%) | 141.60M +9.4M (+7.1%) | 0.66% -0.036 pp | 0.48% +0.029 pp | USD184.47 +164.1% | 21 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 289.9K -23.0K (-7.4%) | 141.27M +10.1M (+7.7%) | 0.66% -0.032 pp | 0.02% +0.001 pp | USD150.62 +223.5% | 73 qtrs — |
| 28 | JPMORGAN CHASE & CO | 262.2K +14.3K (+5.8%) | 127.76M +23.8M (+22.9%) | 0.60% +0.049 pp | 0.01% +0.002 pp | USD242.86 +100.6% | 51 qtrs — |
| 29 | LORD, ABBETT & CO. LLC | 258.0K -11.0K (-4.1%) | 125.73M +12.9M (+11.5%) | 0.59% -0.008 pp | 0.39% +0.050 pp | USD322.98 +50.9% | 7 qtrs — |
| 30 | EVERSEPT PARTNERS, LP | 252.6K -628.0 (-0.2%) | 123.08M +16.9M (+15.9%) | 0.58% +0.015 pp | 6.20% -1.114 pp | USD367.10 +32.7% | 23 qtrs — |
| 31 | NUVEEN, LLC | 251.8K -35.3K (-12.3%) | 122.69M +2.4M (+2.0%) | 0.57% -0.062 pp | 0.03% +0.000 pp | USD322.09 +51.3% | 4 qtrs — |
| 32 | PACER ADVISORS, INC. | 241.9K -97.2K (-28.7%) | 117.85M -24.3M (-17.1%) | 0.55% -0.200 pp | 0.30% -0.057 pp | USD246.60 +97.6% | 26 qtrs — |
| 33 | VICTORY CAPITAL MANAGEMENT INC | 228.4K +118.6K (+108.1%) | 111.28M +65.3M (+141.9%) | 0.52% +0.278 pp | 0.06% +0.036 pp | USD383.42 +27.1% | 30 qtrs — |
| 34 | UBS GROUP AG | 225.8K +70.4K (+45.3%) | 110.04M +44.9M (+68.9%) | 0.52% +0.171 pp | 0.02% +0.008 pp | USD369.04 +32.0% | 45 qtrs — |
| 35 | CAPTION MANAGEMENT, LLC | 222.8K -30.8K (-12.1%) | 108.56M +2.2M (+2.1%) | 0.51% -0.054 pp | 0.74% -0.085 pp | USD400.39 +21.7% | 7 qtrs — |
| 36 | FIRST TRUST ADVISORS LP | 219.0K -81.5K (-27.1%) | 106.72M -19.3M (-15.3%) | 0.50% -0.166 pp | 0.08% -0.016 pp | USD208.44 +133.8% | 51 qtrs — |
| 37 | JANE STREET GROUP, LLC | 216.8K +169.6K (+359.6%) | 105.65M +85.9M (+434.2%) | 0.50% +0.390 pp | 0.02% +0.013 pp | USD459.55 +6.0% | 23 qtrs — |
| 38 | ALLIANCEBERNSTEIN L.P. | 206.5K +26.1K (+14.5%) | 100.64M +25.0M (+33.1%) | 0.47% +0.072 pp | 0.03% +0.008 pp | USD289.13 +68.5% | 61 qtrs — |
| 39 | BANK OF AMERICA CORP /DE/ | 205.1K +12.3K (+6.4%) | 99.95M +19.1M (+23.6%) | 0.47% +0.041 pp | 0.01% +0.002 pp | USD277.12 +75.8% | 52 qtrs — |
| 40 | UBS ASSET MANAGEMENT AMERICAS INC | 203.4K +158.0 (+0.1%) | 99.08M +13.9M (+16.3%) | 0.46% +0.014 pp | 0.02% +0.003 pp | USD243.45 +100.1% | 82 qtrs — |
| 41 | ACADIAN ASSET MANAGEMENT LLC | 200.5K +60.7K (+43.4%) | 97.67M +39.1M (+66.7%) | 0.46% +0.148 pp | 0.16% +0.058 pp | USD357.32 +36.4% | 50 qtrs — |
| 42 | CITADEL ADVISORS LLC | 187.2K -86.8K (-31.7%) | 91.20M -23.7M (-20.6%) | 0.43% -0.180 pp | 0.01% -0.004 pp | USD357.42 +36.3% | 5 qtrs — |
| 43 | POINT72 ASSET MANAGEMENT, L.P. | 186.2K +86.4K (+86.6%) | 90.71M +48.9M (+116.8%) | 0.43% +0.204 pp | 0.10% +0.031 pp | USD450.78 +8.1% | 2 qtrs — |
| 44 | CITIGROUP INC | 184.4K -367.1K (-66.6%) | 89.85M -141.3M (-61.1%) | 0.42% -0.802 pp | 0.04% -0.063 pp | USD410.77 +18.6% | 106 qtrs — |
| 45 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 182.5K -641.8K (-77.9%) | 88.92M -256.6M (-74.3%) | 0.42% -1.411 pp | 0.01% -0.029 pp | USD391.10 +24.6% | 51 qtrs — |
| 46 | FRONTIER CAPITAL MANAGEMENT CO LLC | 181.2K +7.2K (+4.2%) | 88.28M +15.4M (+21.1%) | 0.41% +0.028 pp | 0.94% +0.283 pp | USD336.06 +45.0% | 24 qtrs — |
| 47 | FRANKLIN RESOURCES INC | 181.1K +118.5K (+189.0%) | 88.25M +62.0M (+235.9%) | 0.41% +0.275 pp | 0.02% +0.015 pp | USD432.83 +12.6% | 22 qtrs — |
| 48 | LEGAL & GENERAL GROUP PLC | 173.6K -26.1K (-13.1%) | 84.58M +884.9K (+1.1%) | 0.40% -0.046 pp | 0.02% +0.000 pp | USD192.10 +153.6% | 44 qtrs — |
| 49 | AMUNDI | 163.2K +33.2K (+25.5%) | 79.52M +20.6M (+35.0%) | 0.37% +0.084 pp | 0.02% +0.003 pp | USD346.27 +40.7% | 19 qtrs — |
| 50 | COMERICA BANK | 161.7K +3.7K (+2.4%) | 78.78M +12.6M (+19.0%) | 0.37% +0.019 pp | 0.31% +0.065 pp | USD245.74 +98.3% | 11 qtrs — |
| 51 | SOFINNOVA INVESTMENTS, INC. | 157.6K -33.0K (-17.3%) | 76.81M -3.1M (-3.9%) | 0.36% -0.063 pp | 3.31% -1.058 pp | USD337.23 +44.5% | 3 qtrs — |
| 52 | SEIZERT CAPITAL PARTNERS, LLC | 145.5K -1.5K (-1.0%) | 70.91M +9.3M (+15.1%) | 0.33% +0.006 pp | 3.00% +0.325 pp | USD297.39 +63.8% | 24 qtrs — |
| 53 | HSBC HOLDINGS PLC | 143.6K -12.7K (-8.1%) | 70.05M +4.5M (+6.8%) | 0.33% -0.019 pp | 0.04% -0.001 pp | USD320.28 +52.1% | 56 qtrs — |
| 54 | EPOCH INVESTMENT PARTNERS, INC. | 142.3K -63.5K (-30.9%) | 69.33M -16.9M (-19.6%) | 0.32% -0.131 pp | 0.39% -0.080 pp | USD235.91 +106.5% | 18 qtrs — |
| 55 | CANDRIAM S.C.A. | 127.2K +3.8K (+3.1%) | 61.99M +10.3M (+19.8%) | 0.29% +0.017 pp | 0.31% +0.038 pp | USD354.92 +37.3% | 12 qtrs — |
| 56 | DEUTSCHE BANK AG\ | 124.5K +5.4K (+4.6%) | 60.65M +10.7M (+21.5%) | 0.28% +0.020 pp | 0.02% +0.003 pp | USD264.16 +84.5% | 50 qtrs — |
| 57 | RHUMBLINE ADVISERS | 121.8K -7.1K (-5.5%) | 59.32M +5.3M (+9.8%) | 0.28% -0.008 pp | 0.05% +0.005 pp | USD130.26 +274.1% | 51 qtrs — |
| 58 | TRI LOCUM PARTNERS LP | 120.9K -1.3K (-1.0%) | 58.92M +7.7M (+15.0%) | 0.28% +0.005 pp | 7.65% -4.123 pp | USD419.21 +16.2% | 2 qtrs — |
| 59 | THRIVENT FINANCIAL FOR LUTHERANS | 120.8K -56.0K (-31.7%) | 58.87M -15.2M (-20.6%) | 0.28% -0.116 pp | 0.10% -0.041 pp | USD340.15 +43.2% | 73 qtrs — |
| 60 | SWISS NATIONAL BANK | 117.7K -5.7K (-4.6%) | 57.37M +5.6M (+10.8%) | 0.27% -0.005 pp | 0.03% +0.004 pp | USD172.75 +182.1% | 51 qtrs — |
| 61 | ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 113.9K +22.8K (+25.0%) | 55.47M +17.3M (+45.3%) | 0.26% +0.058 pp | 0.08% +0.024 pp | USD296.17 +64.5% | 43 qtrs — |
| 62 | TD ASSET MANAGEMENT INC | 113.1K -25.7K (-18.5%) | 55.13M -3.1M (-5.3%) | 0.26% -0.050 pp | 0.04% -0.003 pp | USD281.66 +73.0% | 17 qtrs — |
| 63 | GOLDMAN SACHS GROUP INC | 110.8K +29.2K (+35.9%) | 53.97M +19.8M (+57.9%) | 0.25% +0.072 pp | 0.01% +0.002 pp | USD329.23 +48.0% | 73 qtrs — |
| 64 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 104.8K +15.0K (+16.7%) | 52.05M +12.7M (+32.3%) | 0.24% +0.040 pp | 0.08% +0.021 pp | USD294.92 +65.2% | 17 qtrs — |
| 65 | ORBIMED ADVISORS LLC | 105.2K -9.7K (-8.4%) | 51.26M +3.1M (+6.4%) | 0.24% -0.015 pp | 1.05% -0.085 pp | USD419.21 +16.2% | 2 qtrs — |
| 66 | POLARIS CAPITAL MANAGEMENT, LLC | 103.7K -18.4K (-15.1%) | 50.50M -661.1K (-1.3%) | 0.24% -0.034 pp | 4.19% +0.827 pp | USD193.42 +151.9% | 20 qtrs — |
| 67 | AMERIPRISE FINANCIAL INC | 101.0K +37.7K (+59.4%) | 49.23M +22.7M (+85.3%) | 0.23% +0.090 pp | 0.01% +0.005 pp | USD270.08 +80.4% | 55 qtrs — |
| 68 | QUBE RESEARCH & TECHNOLOGIES LTD | 98.3K +68.7K (+232.1%) | 47.90M +35.5M (+286.0%) | 0.22% +0.159 pp | 0.05% +0.036 pp | USD435.18 +12.0% | 23 qtrs — |
| 69 | PRINCIPAL FINANCIAL GROUP INC | 98.2K -7.6K (-7.2%) | 47.83M +3.5M (+7.9%) | 0.22% -0.010 pp | 0.02% +0.002 pp | USD213.90 +127.8% | 71 qtrs — |
| 70 | RETIREMENT SYSTEMS OF ALABAMA | 97.3K -3.0K (-3.0%) | 47.39M +5.4M (+12.7%) | 0.22% 0.000 pp | 0.15% +0.014 pp | USD164.01 +197.1% | 52 qtrs — |
| 71 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 92.2K -2.5K (-2.7%) | 44.90M +5.2M (+13.1%) | 0.21% +0.000 pp | 0.03% +0.004 pp | USD228.88 +112.9% | 24 qtrs — |
| 72 | KRENSAVAGE ASSET MANAGEMENT, LLC | 91.3K -6.4K (-6.5%) | 44.48M +3.5M (+8.7%) | 0.21% -0.008 pp | 15.71% -1.731 pp | USD135.12 +260.6% | 45 qtrs — |
| 73 | WELLS FARGO & COMPANY/MN | 90.9K +12.8K (+16.4%) | 44.31M +11.6M (+35.3%) | 0.21% +0.034 pp | 0.01% +0.002 pp | USD274.04 +77.8% | 57 qtrs — |
| 74 | BARCLAYS PLC | 90.9K +32.3K (+55.2%) | 44.30M +23.3M (+111.0%) | 0.21% +0.078 pp | 0.01% +0.005 pp | USD341.03 +42.9% | 51 qtrs — |
| 75 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 83.4K -63.3K (-43.2%) | 40.62M -20.9M (-33.9%) | 0.19% -0.135 pp | 0.02% -0.014 pp | USD197.67 +146.5% | 58 qtrs — |
| 76 | GOTHAM ASSET MANAGEMENT, LLC | 80.0K -939.0 (-1.2%) | 38.99M +5.1M (+14.9%) | 0.18% +0.003 pp | 0.14% -0.005 pp | USD267.24 +82.3% | 61 qtrs — |
| 77 | MAN GROUP PLC | 79.0K +16.0K (+25.3%) | 38.49M +12.1M (+45.6%) | 0.18% +0.041 pp | 0.07% +0.020 pp | USD311.21 +56.6% | 24 qtrs — |
| 78 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 69.4K -139.2K (-66.7%) | 33.80M -53.6M (-61.3%) | 0.16% -0.304 pp | 0.02% -0.035 pp | USD317.56 +53.4% | 10 qtrs — |
| 79 | AMERICAN CENTURY COMPANIES INC | 68.0K +31.8K (+88.1%) | 33.11M +18.0M (+118.6%) | 0.16% +0.075 pp | 0.02% +0.009 pp | USD377.20 +29.2% | 23 qtrs — |
| 80 | PFM HEALTH SCIENCES, LP | 67.7K -27.9K (-29.2%) | 33.01M -7.1M (-17.7%) | 0.15% -0.057 pp | 3.29% +0.208 pp | USD369.04 +32.0% | 5 qtrs — |
| 81 | BRIDGEWATER ASSOCIATES, LP | 64.6K +48.5K (+302.1%) | 31.47M +24.7M (+367.3%) | 0.15% +0.112 pp | 0.11% +0.088 pp | USD447.72 +8.8% | 15 qtrs — |
| 82 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 64.5K +64.5K (+100.0%) | 31.47M +31.5M (+100.0%) | 0.15% +0.147 pp | 0.04% +0.036 pp | USD487.25 +0.0% | 7 qtrs — |
| 83 | NOMURA HOLDINGS INC | 64.3K -50.4K (-43.9%) | 31.33M -16.8M (-34.8%) | 0.15% -0.108 pp | 0.04% -0.033 pp | USD419.21 +16.2% | 4 qtrs — |
| 84 | MILLENNIUM MANAGEMENT LLC | 64.1K -194.5K (-75.2%) | 31.22M -77.2M (-71.2%) | 0.15% -0.427 pp | 0.01% -0.033 pp | USD380.49 +28.1% | 35 qtrs — |
| 85 | FIRST TURN MANAGEMENT, LLC | 63.6K -21.7K (-25.5%) | 30.98M -4.8M (-13.4%) | 0.15% -0.044 pp | 3.54% -1.831 pp | USD419.21 +16.2% | 2 qtrs — |
| 86 | ATWOOD & PALMER INC | 63.5K -348.0 (-0.5%) | 30.96M +4.2M (+15.6%) | 0.15% +0.003 pp | 1.76% +0.186 pp | USD236.62 +105.9% | 15 qtrs — |
| 87 | HRT FINANCIAL LP | 63.4K -12.2K (-16.2%) | 30.89M -818.0K (-2.6%) | 0.14% -0.023 pp | 0.10% -0.019 pp | USD419.21 +16.2% | 2 qtrs — |
| 88 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 63.3K -881.0 (-1.4%) | 30.84M +3.9M (+14.6%) | 0.14% +0.002 pp | 0.03% +0.003 pp | USD138.53 +251.7% | 52 qtrs — |
| 89 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 61.7K -591.0 (-0.9%) | 30.33M +4.2M (+16.2%) | 0.14% +0.003 pp | 0.02% +0.004 pp | USD256.12 +90.2% | 51 qtrs — |
| 90 | TOCQUEVILLE ASSET MANAGEMENT L.P. | 61.1K -599.0 (-1.0%) | 29.79M +3.9M (+15.1%) | 0.14% +0.003 pp | 0.43% +0.058 pp | USD287.35 +69.6% | 3 qtrs — |
| 91 | WEDGE CAPITAL MANAGEMENT L L P/NC | 60.7K -5.9K (-8.8%) | 29.57M +1.7M (+6.0%) | 0.14% -0.009 pp | 0.53% +0.058 pp | USD249.02 +95.7% | 8 qtrs — |
| 92 | SOLEUS CAPITAL MANAGEMENT, L.P. | 60.0K -90.0K (-60.0%) | 29.24M -33.6M (-53.5%) | 0.14% -0.196 pp | 1.08% -2.087 pp | USD255.79 +90.5% | 18 qtrs — |
| 93 | IEQ CAPITAL, LLC | 59.0K +46.7K (+381.5%) | 28.73M +23.6M (+459.6%) | 0.13% +0.108 pp | 0.09% +0.070 pp | USD460.08 +5.9% | 6 qtrs — |
| 94 | DEKABANK DEUTSCHE GIROZENTRALE | 93.5K +— (+0.0%) | 24.21M -15.2M (-38.6%) | 0.21% +0.006 pp | 0.04% -0.025 pp | USD202.39 +140.7% | 22 qtrs — |
| 95 | — | 130.0K +130.0K (+100.0%) | 633.4K +633.4K (+100.0%) | 0.30% +0.297 pp | 0.48% +0.482 pp | USD487.25 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.09
Bearish
Ratio by volume
0.77
Neutral
Buys
40
Sells
435
Shares acquired
1.19M
Shares disposed
1.55M
Cash buys
—
Cash sales
393.00
Net activity
-358,010
Insider buys vs sells (history)
From
To
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.33M
Shares Outstanding
43.83M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.55M | — | 6.07M | 6.08M | 4.28M | 68.3K | 18.04M | 67.32% | ↗ |
| 2 | 2025 | Michael Benkowitz President and Chief Operating Officer | 1.44M | — | 3.12M | 3.12M | 3.32M | 3.38M | 14.39M | 43.42% | ↗ |
| 3 | 2025 | James Edgemond Chief Financial Officer and Treasurer | 955.8K | — | 1.95M | 1.95M | 1.62M | 1.87M | 8.35M | 46.76% | ↗ |
| 4 | 2025 | Paul Mahon Executive Vice President and General Counsel | 964.2K | — | 1.52M | 1.52M | 1.50M | 29.5K | 5.53M | 54.91% | ↗ |
| 5 | 2024 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.51M | — | 7.59M | 8.02M | 5.63M | 257.6K | 23.01M | 67.86% | ↗ |
| 6 | 2024 | Michael Benkowitz President and Chief Operating Officer | 1.19M | — | 3.90M | 4.12M | 3.06M | 1.62M | 13.89M | 57.79% | ↗ |
| 7 | 2024 | James Edgemond Chief Financial Officer and Treasurer | 860.6K | — | 2.44M | 2.58M | 1.97M | 1.32M | 9.16M | 54.76% | ↗ |
| 8 | 2024 | Paul Mahon Executive Vice President and General Counsel | 940.0K | — | 1.90M | 2.00M | 1.97M | 146.5K | 6.96M | 56.05% | ↗ |
| 9 | 2023 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.48M | — | 5.38M | 5.93M | 4.16M | 17.8K | 16.96M | 66.65% | ↗ |
| 10 | 2023 | Michael Benkowitz President and Chief Operating Officer | 1.10M | — | 2.58M | 2.85M | 2.13M | 1.15M | 9.81M | 55.32% | ↗ |
| 11 | 2023 | James Edgemond Chief Financial Officer and Treasurer | 790.4K | — | 1.51M | 1.66M | 1.33M | 767.9K | 6.05M | 52.27% | ↗ |
| 12 | 2023 | Paul Mahon Executive Vice President and General Counsel | 940.0K | — | 1.29M | 1.42M | 1.46M | 41.1K | 5.15M | 52.63% | ↗ |
| 13 | 2022 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.40M | — | — | — | 3.91M | 10.8K | 5.32M | 0.00% | ↗ |
| 14 | 2022 | Michael Benkowitz President and Chief Operating Officer | 973.3K | — | — | — | 1.84M | 14.2K | 2.83M | 0.00% | ↗ |
| 15 | 2022 | Paul Mahon Executive Vice President and General Counsel | 934.2K | — | — | — | 1.35M | 24.6K | 2.31M | 0.00% | ↗ |
| 16 | 2022 | James Edgemond Chief Financial Officer and Treasurer | 745.2K | — | — | — | 1.24M | 17.4K | 2.01M | 0.00% | ↗ |
| 17 | 2021 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.37M | — | — | — | 2.13M | 10.4K | 3.51M | 0.00% | ↗ |
| 18 | 2021 | Michael Benkowitz President and Chief Operating Officer | 940.4K | — | — | — | 1.00M | 372.0K | 2.32M | 0.00% | ↗ |
| 19 | 2021 | James Edgemond Chief Financial Officer and Treasurer | 721.2K | — | — | — | 679.7K | 502.4K | 1.90M | 0.00% | ↗ |
| 20 | 2021 | Paul Mahon Executive Vice President and General Counsel | 905.4K | — | — | — | 739.4K | 22.4K | 1.67M | 0.00% | ↗ |
| 21 | 2020 | Michael Benkowitz President and Chief Operating Officer | 944.4K | — | — | — | 1.00M | 3.18M | 5.13M | 0.00% | ↗ |
| 22 | 2020 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.35M | — | — | — | 1.87M | 1.59M | 4.81M | 0.00% | ↗ |
| 23 | 2020 | Paul Mahon Executive Vice President and General Counsel | 908.1K | — | — | — | 737.9K | 2.46M | 4.10M | 0.00% | ↗ |
| 24 | 2020 | James Edgemond Chief Financial Officer and Treasurer | 722.1K | — | — | — | 677.3K | 1.81M | 3.21M | 0.00% | ↗ |
| 25 | 2019 | Martine Rothblatt Chairman and Chief Executive Officer | 1.22M | — | — | 40.01M | 1.75M | 2.65M | 45.64M | 87.67% | ↗ |
| 26 | 2019 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.22M | — | — | 40.01M | 1.75M | 2.65M | 45.64M | 87.67% | ↗ |
| 27 | 2019 | Michael Benkowitz President and Chief Operating Officer | 845.6K | — | — | 15.00M | 940.3K | 2.85M | 19.64M | 76.41% | ↗ |
| 28 | 2019 | Paul Mahon Executive Vice President and General Counsel | 812.7K | — | — | 12.00M | 690.6K | 3.06M | 16.57M | 72.45% | ↗ |
| 29 | 2019 | James Edgemond Chief Financial Officer and Treasurer | 645.2K | — | — | 13.00M | 632.8K | 1.69M | 15.97M | 81.43% | ↗ |
| 30 | 2018 | Martine Rothblatt Chairman and Chief Executive Officer | 1.21M | — | — | 12.80M | 2.02M | 9.8K | 16.04M | 79.80% | ↗ |
| 31 | 2018 | Martine Rothblatt Chairperson and Chief Executive Officer | 1.21M | — | — | 12.80M | 2.02M | 9.8K | 16.04M | 79.80% | ↗ |
| 32 | 2018 | Michael Benkowitz President and Chief Operating Officer | 833.3K | — | — | 3.84M | 1.08M | 853.2K | 6.61M | 58.09% | ↗ |
| 33 | 2018 | Paul Mahon Executive Vice President and General Counsel | 820.0K | — | — | 3.66M | 799.5K | 21.8K | 5.30M | 69.02% | ↗ |
| 34 | 2018 | James Edgemond Chief Financial Officer and Treasurer | 645.8K | — | — | 3.38M | 731.3K | 483.6K | 5.24M | 64.51% | ↗ |
| 35 | 2017 | Martine Rothblatt Chairman and Chief Executive Officer | 1.16M | — | — | 33.12M | 1.60M | 1.25M | 37.13M | 89.20% | ↗ |
| 36 | 2017 | Paul Mahon Executive Vice President and General Counsel | 816.0K | — | — | 9.98M | 656.3K | 1.42M | 12.87M | 77.52% | ↗ |
| 37 | 2017 | Michael Benkowitz President and Chief Operating Officer | 733.3K | — | — | 9.02M | 738.8K | 1.07M | 11.56M | 78.03% | ↗ |
| 38 | 2017 | James Edgemond Chief Financial Officer and Treasurer | 620.8K | — | — | 6.58M | 577.1K | 871.7K | 8.65M | 76.08% | ↗ |
| 39 | 2016 | Roger Jeffs Former President and Co-CEO | 484.9K | — | — | 10.49M | — | 6.04M | 17.01M | 61.66% | ↗ |
| 40 | 2016 | Martine Rothblatt Chairman and Chief Executive Officer | 1.23M | — | — | 12.58M | 992.5K | 621.0K | 15.42M | 81.58% | ↗ |
| 41 | 2016 | Paul Mahon Executive Vice President and General Counsel | 942.7K | — | — | 5.24M | 413.8K | 1.03M | 7.63M | 68.74% | ↗ |
| 42 | 2016 | Michael Benkowitz President and Chief Operating Officer | 568.4K | — | — | 3.57M | 416.0K | 796.2K | 5.35M | 66.73% | ↗ |
| 43 | 2016 | James Edgemond Chief Financial Officer and Treasurer | 591.0K | — | — | 2.10M | 360.0K | 1.06M | 4.11M | 51.04% | ↗ |
| 44 | 2016 | David Zaccardelli Former Executive Vice President and Chief Operating Officer | 343.7K | — | — | 3.15M | — | 15.4K | 3.51M | 89.76% | ↗ |
| 45 | 2015 | Roger Jeffs President and Co-Chief Executive Officer | 925.0K | — | — | 14.40M | 899.1K | 610.9K | 16.83M | 85.53% | ↗ |
| 46 | 2015 | Roger Jeffs Former President and Co-CEO | 925.0K | — | — | 14.40M | 899.1K | 610.9K | 16.83M | 85.53% | ↗ |
| 47 | 2015 | John Ferrari Former Chief Financial Officer | 225.7K | — | — | 6.95M | — | 1.85M | 9.03M | 76.97% | ↗ |
| 48 | 2015 | Paul Mahon Executive Vice President and General Counsel | 760.2K | — | — | 6.95M | 495.8K | 321.4K | 8.53M | 81.51% | ↗ |
| 49 | 2015 | David Zaccardelli Former Executive Vice President and Chief Operating Officer | 500.0K | — | — | 4.53M | 324.0K | 377.9K | 5.73M | 79.03% | ↗ |
| 50 | 2015 | David Zaccardelli Executive Vice President and Chief Operating Officer | 500.0K | — | — | 4.53M | 324.0K | 377.9K | 5.73M | 79.03% | ↗ |
| 51 | 2015 | James Edgemond Chief Financial Officer and Treasurer | 380.1K | — | — | 2.40M | 216.0K | 13.4K | 3.01M | 79.76% | ↗ |
| 52 | 2015 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 1.08M | — | — | — | 1.17M | 18.6K | 2.27M | 0.00% | ↗ |
| 53 | 2015 | Martine Rothblatt Chairman and Chief Executive Officer | 1.08M | — | — | — | 1.17M | 18.6K | 2.27M | 0.00% | ↗ |
| 54 | 2014 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 1.02M | — | — | 29.46M | 1.07M | 1.66M | 33.21M | 88.70% | ↗ |
| 55 | 2014 | Martine Rothblatt Chairman and Chief Executive Officer | 1.02M | — | — | 29.46M | 1.07M | 1.66M | 33.21M | 88.70% | ↗ |
| 56 | 2014 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 1.02M | — | — | 29.46M | 1.07M | 23.3K | 33.21M | 88.70% | ↗ |
| 57 | 2014 | Roger Jeffs President and Co-Chief Executive Officer | 840.4K | — | — | 5.93M | 653.4K | 1.42M | 8.85M | 67.03% | ↗ |
| 58 | 2014 | Roger Jeffs Former President and Co-CEO | 840.4K | — | — | 5.93M | 653.4K | 1.42M | 8.85M | 67.03% | ↗ |
| 59 | 2014 | Roger Jeffs President and Co-Chief Executive Officer | 840.4K | — | — | 5.93M | 653.4K | 25.2K | 8.85M | 67.03% | ↗ |
| 60 | 2014 | John Ferrari Chief Financial Officer | 565.5K | — | — | 4.24M | 351.8K | 14.6K | 6.65M | 63.71% | ↗ |
| 61 | 2014 | John Ferrari Former Chief Financial Officer | 565.5K | — | — | 4.24M | 351.8K | 1.50M | 6.65M | 63.71% | ↗ |
| 62 | 2014 | Paul Mahon Executive Vice President and General Counsel | 731.0K | — | — | 4.24M | 454.7K | 1.23M | 6.65M | 63.72% | ↗ |
| 63 | 2014 | Paul Mahon Executive Vice President and General Counsel | 731.0K | — | — | 4.24M | 454.7K | 16.4K | 6.65M | 63.72% | ↗ |
| 64 | 2013 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 992.7K | — | — | 36.10M | 1.10M | 25.3K | 38.22M | 94.45% | ↗ |
| 65 | 2013 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 992.7K | — | — | 36.10M | 1.10M | 25.3K | 38.22M | 94.45% | ↗ |
| 66 | 2013 | Martine Rothblatt Chief Executive Officer | 992.7K | — | — | 36.10M | 1.10M | 25.3K | 38.22M | 94.45% | ↗ |
| 67 | 2013 | Roger Jeffs President and Co-Chief Executive Officer | 808.1K | — | — | 4.07M | 671.0K | 25.5K | 5.57M | 73.00% | ↗ |
| 68 | 2013 | Roger Jeffs President and Chief Operating Officer | 808.1K | — | — | 4.07M | 671.0K | 25.5K | 5.57M | 73.00% | ↗ |
| 69 | 2013 | Roger Jeffs President and Co-Chief Executive Officer | 808.1K | — | — | 4.07M | 671.0K | 25.5K | 5.57M | 73.00% | ↗ |
| 70 | 2013 | John Ferrari Chief Financial Officer | 543.8K | — | — | 2.90M | 361.2K | 13.4K | 4.26M | 68.22% | ↗ |
| 71 | 2013 | John Ferrari Former Chief Financial Officer | 543.8K | — | — | 2.90M | 361.2K | 448.4K | 4.26M | 68.22% | ↗ |
| 72 | 2013 | Paul Mahon Executive Vice President and General Counsel | 702.9K | — | — | 2.90M | 466.9K | 16.4K | 4.09M | 71.01% | ↗ |
| 73 | 2013 | Paul Mahon Executive Vice President and General Counsel | 702.9K | — | — | 2.90M | 466.9K | 16.4K | 4.09M | 71.01% | ↗ |
| 74 | 2012 | Martine Rothblatt Chairman and Co-Chief Executive Officer | 959.6K | — | — | 3.02M | 983.4K | 26.3K | 7.96M | 38.01% | ↗ |
| 75 | 2012 | Martine Rothblatt Chief Executive Officer | 959.6K | — | — | 3.02M | 983.4K | 26.3K | 7.96M | 38.01% | ↗ |
| 76 | 2012 | Roger Jeffs President and Chief Operating Officer | 778.2K | — | — | 3.18M | 598.2K | 25.1K | 6.82M | 46.70% | ↗ |
| 77 | 2012 | Roger Jeffs President and Co-Chief Executive Officer | 778.2K | — | — | 3.18M | 598.2K | 25.1K | 6.82M | 46.70% | ↗ |
| 78 | 2012 | Paul Mahon Executive Vice President and General Counsel | 676.9K | — | — | 2.27M | 416.3K | 14.1K | 5.31M | 42.83% | ↗ |
| 79 | 2012 | John Ferrari Chief Financial Officer and Treasurer | 514.8K | — | — | 2.27M | 332.1K | 12.6K | 4.76M | 47.77% | ↗ |
| 80 | 2012 | John Ferrari Chief Financial Officer | 514.8K | — | — | 2.27M | 322.1K | 12.6K | 4.76M | 47.77% | ↗ |
| 81 | 2011 | Roger Jeffs President and Chief Operating Officer | 754.3K | — | — | 2.70M | 489.7K | 23.9K | 4.78M | 56.36% | ↗ |
| 82 | 2011 | Paul Mahon Executive Vice President and General Counsel | 656.2K | — | — | 1.93M | 340.8K | 13.8K | 3.62M | 53.21% | ↗ |
| 83 | 2011 | John Ferrari Chief Financial Officer and Treasurer | 463.1K | — | — | 1.93M | 236.1K | 13.4K | 3.40M | 56.61% | ↗ |
| 84 | 2011 | Martine Rothblatt Chief Executive Officer | 931.5K | — | — | — | 805.0K | 15.2K | 3.16M | 0.00% | ↗ |
| 85 | 2010 | Martine Rothblatt Chief Executive Officer | 874.8K | — | — | — | 900.0K | 56.2K | 17.62M | 0.00% | ↗ |
| 86 | 2010 | Roger Jeffs President and Chief Operating Officer | 725.0K | — | — | 4.55M | 550.0K | 39.3K | 6.81M | 66.80% | ↗ |
| 87 | 2010 | Paul Mahon Executive Vice President and General Counsel | 630.0K | — | — | 3.25M | 375.0K | 13.8K | 5.06M | 64.14% | ↗ |
| 88 | 2010 | John Ferrari Chief Financial Officer and Treasurer | 437.7K | — | — | 3.25M | 250.0K | 9.9K | 4.77M | 68.09% | ↗ |
| 89 | 2009 | Martine Rothblatt Chief Executive Officer | 798.2K | — | — | 14.58M | 440.1K | 19.3K | 17.59M | 82.87% | ↗ |
| 90 | 2009 | Roger Jeffs President and Chief Operating Officer | 710.0K | — | — | 6.36M | 288.2K | 12.0K | 8.67M | 73.29% | ↗ |
| 91 | 2009 | Roger Jeffs President and Chief Operating | 710.0K | — | — | — | 288.2K | 12.0K | 8.67M | 0.00% | ↗ |
| 92 | 2009 | Paul Mahon Executive Vice President and General Counsel | 615.0K | — | — | 4.69M | 194.9K | 13.7K | 6.58M | 71.18% | ↗ |
| 93 | 2009 | Paul Mahon Executive Vice President, Strategic Planning and | 615.0K | — | — | — | 194.9K | 13.7K | 6.58M | 0.00% | ↗ |
| 94 | 2009 | John Ferrari Chief Financial Officer and Treasurer | 407.7K | — | — | 4.33M | 118.7K | 9.7K | 5.67M | 76.34% | ↗ |
| 95 | 2008 | Roger Jeffs President and Chief Operating Officer | 701.3K | 14.6K | — | — | 409.8K | 8.2K | 11.32M | 0.00% | ↗ |
| 96 | 2008 | Roger Jeffs President and Chief Operating | 701.3K | 14.6K | — | — | 409.8K | 8.2K | 11.32M | 0.00% | ↗ |
| 97 | 2008 | Paul Mahon Executive Vice President, Strategic Planning and | 607.5K | 9.8K | — | — | 274.6K | 10.2K | 8.32M | 0.00% | ↗ |
| 98 | 2008 | Paul Mahon Executive Vice President and General Counsel | 607.5K | 9.8K | — | — | 274.6K | 10.2K | 8.32M | 0.00% | ↗ |
| 99 | 2008 | John Ferrari Chief Financial Officer and Treasurer | 380.0K | 6.0K | — | — | 169.0K | 8.4K | 5.91M | 0.00% | ↗ |
| 100 | 2008 | Martine Rothblatt Chief Executive Officer | 796.3K | 22.5K | — | — | 633.8K | 15.9K | 5.57M | 0.00% | ↗ |
| 101 | 2007 | Martine Rothblatt Chief Executive Officer | 767.1K | 12.0K | — | — | 588.0K | 19.8K | 25.34M | 0.00% | ↗ |
| 102 | 2007 | Roger Jeffs President and Chief Operating Officer | 668.8K | 8.4K | — | — | 411.6K | 8.9K | 4.41M | 0.00% | ↗ |
| 103 | 2007 | Roger Jeffs President and Chief Operating | 668.8K | 8.4K | — | — | 411.6K | 8.9K | 4.31M | 0.00% | ↗ |
| 104 | 2007 | Paul Mahon Executive Vice President, Strategic Planning and | 578.8K | 5.0K | — | — | 345.0K | 10.2K | 3.23M | 0.00% | ↗ |
| 105 | 2007 | John Ferrari Chief Financial Officer and Treasurer | 300.0K | 2.8K | — | — | 137.2K | 7.4K | 1.83M | 0.00% | ↗ |
| 106 | 2006 | Fred Hadeed, CFO | 588.3K | — | — | 5.81M | 75.0K | 1.48M | 7.95M | 73.08% | ↗ |
| 107 | 2006 | Roger Jeffs President and Chief Operating Officer | 650.0K | — | — | — | 210.0K | 8.5K | 6.55M | 0.00% | ↗ |
| 108 | 2006 | Roger Jeffs, President | 650.0K | — | — | 2.55M | 210.0K | 8.5K | 6.55M | 38.90% | ↗ |
| 109 | 2006 | Martine Rothblatt, CEO | 725.0K | — | — | — | 300.0K | 9.5K | 6.24M | 0.00% | ↗ |
| 110 | 2006 | Martine Rothblatt Chief Executive Officer | 725.0K | — | — | — | 300.0K | 9.5K | 6.24M | 0.00% | ↗ |
| 111 | 2006 | Paul Mahon, Exec. VP | 560.0K | — | — | 1.96M | 120.0K | 10.1K | 5.04M | 38.83% | ↗ |
| 112 | 2006 | Paul Mahon Executive Vice President, Strategic Planning and | 560.0K | — | — | — | 120.0K | 10.1K | 5.04M | 0.00% | ↗ |
| 113 | 2006 | John Ferrari, CFO | 199.4K | — | — | 302.6K | 50.0K | 4.7K | 1.14M | 26.59% | ↗ |
| 114 | 2006 | John Ferrari Chief Financial Officer and Treasurer | 199.4K | — | — | — | 25.2K | 4.7K | 1.11M | 0.00% | ↗ |
| 115 | 2005 | Roger Jeffs President and Chief Operating Officer | 600.0K | 120.0K | — | — | — | 3.52M | 4.24M | 0.00% | ↗ |
| 116 | 2005 | Fred T. Hadeed Executive Vice President for Business Development and | 600.0K | 80.0K | — | — | — | 2.89M | 3.57M | 0.00% | ↗ |
| 117 | 2005 | Paul A. Mahon Executive Vice President, Strategic Planning, General | 535.0K | 60.0K | — | — | — | 2.53M | 3.13M | 0.00% | ↗ |
| 118 | 2005 | Martine A. Rothblatt Chairman and Chief Executive Officer | 660.0K | 180.0K | — | — | — | 13.5K | 853.5K | 0.00% | ↗ |
| 119 | 2004 | Roger Jeffs President and Chief Operating Officer | 550.0K | 200.0K | — | — | — | 1.30M | 2.05M | 0.00% | ↗ |
| 120 | 2004 | Fred T. Hadeed Executive Vice President for Business Development and | 500.0K | 125.0K | — | — | — | 618.7K | 1.24M | 0.00% | ↗ |
| 121 | 2004 | Paul A. Mahon Executive Vice President, Strategic Planning, General | 500.0K | 100.0K | — | — | — | 616.3K | 1.22M | 0.00% | ↗ |
| 122 | 2004 | Martine A. Rothblatt Chairman and Chief Executive Officer | 600.0K | 300.0K | — | — | — | 9.8K | 909.8K | 0.00% | ↗ |
| 123 | 2003 | Roger Jeffs President and Chief Operating Officer | 500.0K | 200.0K | — | — | — | 565.8K | 1.27M | 0.00% | ↗ |
| 124 | 2003 | Martine A. Rothblatt Chairman and Chief Executive Officer | 600.0K | — | — | — | — | — | 600.0K | 0.00% | ↗ |
| 125 | 2003 | Paul A. Mahon Executive Vice President, Strategic Planning, General | 400.0K | 150.0K | — | — | — | — | 550.0K | 0.00% | ↗ |
| 126 | 2003 | Fred T. Hadeed Executive Vice President for Business Development and | 400.0K | 150.0K | — | — | — | — | 550.0K | 0.00% | ↗ |
| 127 | 2003 | David Walsh Executive Vice President and Chief Operating Officer for Production | 226.8K | 56.1K | — | — | — | — | 282.9K | 0.00% | ↗ |
| 128 | 2002 | Martine A. Rothblatt Chairman and Chief Executive Officer | 490.6K | 317.5K | — | — | — | — | 808.1K | 0.00% | ↗ |
| 129 | 2002 | Roger Jeffs President and Chief Operating Officer | 288.8K | 227.1K | — | — | — | — | 515.9K | 0.00% | ↗ |
| 130 | 2002 | Paul A. Mahon Senior Vice President, General Counsel and Secretary | 300.0K | 125.3K | — | — | — | — | 425.3K | 0.00% | ↗ |
| 131 | 2002 | Paul A. Mahon Executive Vice President, Strategic Planning, General | 300.0K | 125.3K | — | — | — | — | 425.3K | 0.00% | ↗ |
| 132 | 2002 | Fred T. Hadeed Chief Financial Officer | 264.7K | 120.8K | — | — | — | 841.00 | 386.3K | 0.00% | ↗ |
| 133 | 2002 | Fred T. Hadeed Executive Vice President for Business Development and | 264.7K | 120.8K | — | — | — | — | 385.5K | 0.00% | ↗ |
| 134 | 2002 | David Walsh Executive Vice President and Chief Operating Officer for Production | 210.0K | 54.2K | — | — | — | 251.00 | 264.5K | 0.00% | ↗ |
| 135 | 2002 | David Walsh Executive Vice President and Chief Operating Officer for Production | 210.0K | 54.2K | — | — | — | — | 264.2K | 0.00% | ↗ |
| 136 | 2001 | Martine A. Rothblatt Chairman and Chief Executive Officer | 296.3K | 12.6K | — | — | — | — | 308.9K | 0.00% | ↗ |
| 137 | 2001 | Roger Jeffs President and Chief Operating Officer | 250.1K | 9.2K | — | — | — | — | 259.3K | 0.00% | ↗ |
| 138 | 2001 | Fred T. Hadeed Executive Vice President for Business Development and | 199.9K | 8.7K | — | — | — | — | 208.6K | 0.00% | ↗ |
| 139 | 2001 | Fred T. Hadeed Chief Financial Officer | 199.9K | 8.7K | — | — | — | — | 208.6K | 0.00% | ↗ |
| 140 | 2001 | David Walsh Executive Vice President and Chief Operating Officer for Production | 175.3K | 7.1K | — | — | — | 22.8K | 205.2K | 0.00% | ↗ |
| 141 | 2001 | Paul A. Mahon Senior Vice President, General Counsel and Secretary | 162.5K | 8.8K | — | — | — | — | 171.3K | 0.00% | ↗ |
| 142 | 2001 | Paul A. Mahon Executive Vice President, Strategic Planning, General | 162.5K | 8.8K | — | — | — | — | 171.3K | 0.00% | ↗ |
| 143 | 2000 | Martine A. Rothblatt Chairman and Chief Executive Officer | 244.2K | 109.5K | — | — | — | — | 353.7K | 0.00% | ↗ |
| 144 | 2000 | Roger Jeffs President and Chief Operating Officer | 181.1K | 154.0K | — | — | — | — | 335.1K | 0.00% | ↗ |
| 145 | 2000 | David Walsh Executive Vice President and Chief Operating Officer for Production | 150.0K | 56.9K | — | — | — | 17.2K | 224.1K | 0.00% | ↗ |
| 146 | 2000 | Fred T. Hadeed Chief Financial Officer | 134.6K | 47.7K | — | — | — | — | 182.3K | 0.00% | ↗ |
| 147 | 2000 | Paul A. Mahon Senior Vice President, General Counsel and Secretary | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Martine A. Rothblatt | Founder, Chairman & Chief Executive Officer | 6M | — |
| Michael I. Benkowitz | President & Chief Operating Officer | 5M | male |
| James C. Edgemond | Chief Financial Officer & Treasurer | 3M | male |
| Paul A. Mahon | Executive Vice President, General Counsel & Corporate Secretary | 2M | male |
| Leigh Peterson | Executive Vice President of Product Development & Xenotransplantation | — | — |
| Harrison Silvers | Manager of Investor Relations | — | — |
| Holly Hobson | Associate Vice President of Human Resources | — | female |
| Gil Golden | Senior Vice President & Chief Medical Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-06-11 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-05-12 | 2023-06-22 | Michael McCaul | TX10 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-05-12 | 2023-06-22 | Michael McCaul | TX10 | Spouse | Sale | $100,001 - $250,000 | ↗ |
| 2022-03-01 | 2022-04-18 | Michael McCaul | TX10 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2022-03-01 | 2022-04-18 | Michael McCaul | TX10 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2022-01-28 | 2022-02-23 | Michael McCaul | TX10 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2022-01-28 | 2022-02-23 | Michael McCaul | TX10 | — | Sale | $1,001 - $15,000 | ↗ |
| 2019-03-06 | 2020-04-27 | Donna Shalala | FL27 | -- | Sale (Full) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for UTHR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
